Purpose: Ischemia and reperfusion injury (I/R) of neuronal structures and organs is associated with increased morbidity and mortality due to neuronal cell death. We hypothesized that inhalation of carbon monoxide (CO) after I/R injury ('postconditioning') would protect retinal ganglion cells (RGC).
Introduction
Stroke, an ischemic cerebral injury, is a leading cause of morbidity and mortality in the Western world and may occur in the perioperative period [1] . Perioperative stroke is primarily associated with major cardiovascular procedures but has also been reported after non-cardiac surgery, occurring with an incidence of 0.1% [2] . Pre-clinical evaluation of many neuroprotective strategies showed only modest or inconsistent tissue protection [3] .
The gas carbon monoxide (CO), which is generated in cells almost exclusively through the degradation of heme by heme oxygenase (HO) enzymes, has been shown to protect cells through potential anti-inflammatory, anti-proliferative, or anti-apoptotic effects [4] [5] [6] . Moreover, CO preconditioning has been shown to protect neuronal cells in the brain [7] and the retina [8] . These protective effects of CO involve the modulation of numerous cellular targets including heme-containing enzymes [9] , the mitogen-activated protein kinases (MAPKs) [10] and different transcription factors [11, 12] . The MAPKs (p38, ERK-1/2 and JNK) are a family of protein kinases playing an important role in apoptosis and survival signaling. Depending on stimulus and timing, their activity is differentially regulated by CO [4, 8] .
Inhalation of 125 or 250 ppm CO immediately at the onset of reperfusion reduced total hemispheric infarct volume in transient middle cerebral artery occlusion model by nearly 30% and 60%, respectively, with an extended therapeutic window of 1-3 h after ischemia [13] . However, the effects and the mechanisms of CO postconditioning on neuronal cells in vivo, in particular on retinal ganglion cells (RGC), have not been investigated. The RGC represent a special population of neuronal cells, as they are positioned ''upstream'' of the central nervous system, easily accessible and treatable under visual control. They are often used as an ischemia/reperfusion (I/R) brain injury model to prove neuroprotective strategies [14] [15] [16] . Therefore, we chose the eye as a neuronal organ to analyze and counteract I/R related neuronal damage.
The hypothesis of this study was that CO postconditioning exerts protective effects over a time period of seven days after retinal ischemia. Furthermore, we hypothesized that CO acts as a neuroprotective messenger in vivo via its anti-apoptotic and antiinflammatory effects.
Materials and Methods

Animals and Ethics Statement
Adult male and female Sprague-Dawley rats (1:1, 280-350 g bodyweight, Charles River, Sulzfeld, Germany) were used. Animals were fed with standard rodent diet ad libitum while kept on a 12-h light/12-h dark cycle. All procedures involving the animals concurred with the statement of 'The Association for Research in Vision and Ophthalmology' for the use of animals in research and were approved by the 'Committee of Animal Care of the University of Freiburg' (Permit Number: .81/G-11/ 81). All procedures were performed under adequate anesthesia/ analgesia and all efforts were made to minimize suffering. The number of animals used for RGC quantification and molecular analysis was n = 8 per group and time point. For analysis of mRNA and protein expression retinal tissue was harvested at t = 12, 24, 48 and 72 h after CO inhalation.
Retrograde labeling of RGC
Rats were anesthetized with isoflurane and placed in a stereotactic apparatus (Stoelting, Kiel, Germany) and Fluorogold (FG, 7.8 ml; Fluorochrome, Denver, CO) dissolved in 10% dimethylsulfoxide in PBS was injected into both superior colliculi as described previously [17] . To ensure proper RGC labeling, animals were allowed seven days for retrograde transport of FG before further experimental intervention.
Retinal ischemia/reperfusion injury and carbon monoxide treatment
Retinal ischemia/reperfusion injury of the rats was performed for 1 hour as previously described after intraperitoneal anesthesia with xylazine and ketamine [8] . Rats without immediate recovery of retinal perfusion at the end of the ischemic period or those with lens injuries were excluded from the investigation, since the latter prevents RGC death and promotes axonal regeneration [18] . To evaluate a neuroprotective effect of inhaled CO, animals were randomized to receive treatment either with room air or with room air supplemented with 250 ppm CO (Air Liquide, Kornwestheim, Germany) for 1 hour in an air-sealed chamber immediately following retinal I/R injury, 1,5 h or 3 h after initiation of reperfusion. A fifth group received ERK-1/2-inhibitor PD98059 (2 mg/kg BW via the tailvene, dissolved in DMSO) before initiation of retinal ischemia and subsequent CO inhalation, a sixth group received PD98059 before retinal ischemia without CO postconditioning.
RGC quantification
Animals were sacrificed 7 days after ischemia. After wholemount preparation, densities of FG-positive RGC were determined with a fluorescence microscope (AxioImager; Carl Zeiss, Jena, Germany) and the appropriate bandpass emission filter (FG: excitation/emission, 331/418 nm), as previously described [19] . Immunohistochemical staining (DAPI, GFAP, ERK-1/2 and Thy-1, Ki-67, Iba-1)
Immunohistochemistry was performed to evaluate the expression pattern of glial, neuronal, inflammatory and survival promoting proteins in the retina 48 h after CO inhalation ('postconditioning'). Rat eyes (n = 2 per group) were enucleated and immediately fixed in 4% paraformaldehyde overnight at 4uC. Immunohistochemistry was performed according to standardized protocols with monoclonal antibodies against glial fibrillary acidic protein (GFAP; dilution 1:400; Sigma, Taufkirchen, Germany), ionized calcium binding adaptor molecule 1 (Iba-1; dilution 1:150, Wako, Neuss, Germany), Thy-1.1 (CD90; dilution 1:50; Serotec, Duesseldorf, Germany), pERK-1/2 (#4370; dilution 1:800; Cell Signaling Technology, Danvers, MA, USA) and Ki-67 antigen (dilution 1:100, BD Biosciences, Heidelberg, Germany), which were then conjugated with their corresponding secondary antibody (Cy2 TM ; green fluorescence; dilution 1:200; Jackson ImmunoResearch, West Grove, PA, USA or rhodamin; red fluorescence; dilution 1:50; KPL, Gaithersburg, MD, USA). The nuclei of cells in the retina were stained with 49,6-diamino-2-phenylindole dihydrochloride hydrate (DAPI, Sigma, Taufkirchen, Germany) added to the embedding medium (Mowiol; Calbiochem, San Diego, CA, USA). Slides were examined under a fluorescence microscope (Axiophot; Carl Zeiss, Jena, Germany).
Western blot analysis
Retinal tissue for analysis of protein expression was harvested at four different time points (t = 12, 24, 48 and 72 h). Total protein from L of each retina was extracted, determined, and processed for Western Blot as described previously [8] . The membranes were blocked with 5% skim milk in Tween20/PBS and incubated in the recommended dilution of protein specific antibodies (phospho-ERK-1/2 (#4370), phospho-p38 (#9211), cleaved Caspase-3 (#9664), phospho-NF-kB p65 (#3033), HO-1 (#5141), Bax (#2772) and Bcl-2 (#2870), all Cell Signaling Technology, Danvers, MA, USA) overnight at 4uC. For normalization, blots were re-probed with antibodies to detect total amounts of Caspase-3 (#9665), ERK-1/2 (#4695), p38 (#9212), NF-kB-p65 (#3034, all Cell Signaling Technology, Danvers, MA, USA) and GAPDH (#CSA-335, Enzo Lifesciences, Plymouth, PA, USA). Relative changes in protein expression or phosphorylation in I/R injured retinas either with or without CO were calculated in relation to the corresponding non-ischemic retinas and expressed as ''x-fold change versus non-ischemic retina''.
Electrophoretic mobility shift assay
Electrophoretic mobility shift assays (EMSA) were performed using oligonucleotides containing the consensus binding site for NF-kB (NF-kB consensus sequence 59-AGT TGA GGG GAC TTT CCC AGG-39, Promega, Mannheim, Germany) as previously described [8] . Relative DNA-binding activity of NF-kB in I/ R injured retinas either with or without CO was calculated in relation to the binding activity in the corresponding non-ischemic retinas and expressed as ''x-fold change versus non-ischemic retina''.
Real time polymerase chain reaction
From retinal tissue harvested at different time points (t = 12, 24, 48 and 72 h), total RNA from J of each retina was extracted using a column-purification based kit (RNeasy Micro Kit, Qiagen, Hilden, Germany) according to the manufacturer's instructions. Reverse transcription was performed with 50 ng of total RNA using random primers (High Capacity cDNA Reverse Transcription Kit, Applied Biosystems, Darmstadt, Germany). Real time polymerase chain reactions (RT-PCR) were done with a TaqManH probe-based detection kit (TaqManH PCR universal mastermix, Applied Biosystems, Darmstadt, Germany), using the primers listed in Table 1 (all from Applied Biosystems, Darmstadt, Germany). The PCR assays were then performed on a RT-PCR System (ABI Prism 7000, Applied Biosystems, Darmstadt, Germany) with the following cycling conditions: 95uC for 10 min, 40 cycles of 95uC for 10 sec and 60uC for 1 min. Reaction specificity was confirmed by running appropriate negative controls. Cycle threshold (CT) values for each gene of interest were normalized to the corresponding CT values for GAPDH (DCT). Relative gene expression in I/R injured retinal tissue either with CO or room air was calculated in relation to the corresponding gene expression in the non-injured retinal tissue of each individual animal (DDCT).
Statistical analysis
Data were analyzed by a computerized statistical program (SigmaPlot Version 11.0, Systat Software Inc., San Jose, CA, USA). The nature of the hypothesis testing was two-tailed. We wished to detect a 50% reduction of RGC death through CO intervention. Based on previously published data and power analysis [8] we assumed that a sample size of n = 8 animals per group would be sufficient to detect such reduction. The results are presented as mean values (6SD) after normal distribution of data had been verified. Two-way ANOVA (RT-PCR, WB and EMSA: Factor A = time with four levels: 12, 24, 48 and 72 h; factor B = intervention with two levels: room air and CO; RGC analysis: Factor A = ischemia with two levels: control and I/R injury; factor B = intervention with four levels: I.: 1. room air, 2. CO immediate, 3. CO 1.5 h and 4. CO 3 h; II.: 1. room air, 2. CO, 3. PD98059 and 4. PD98059+CO) was used for between-group comparisons with post hoc Holm-Sidak test. A p-value,0.05 was considered statistically significant.
Results
CO postconditioning suppresses I/R-induced apoptosis
To first answer the question whether CO inhibits I/R-induced retinal apoptosis, mRNA and protein expression of Bax and Bcl-2 were determined. CO postconditioning reduced the retinal mRNA expression of pro-apoptotic Bax at 12, 48 and 72 h ( To confirm the findings of CO-mediated anti-apoptosis after I/ R, we evaluated Caspase-3 expression by RT-PCR and Caspase-3 cleavage using Western blot. Retinal Caspase-3 mRNA expression was reduced when animals inhaled CO after I/R compared to room air inhalation ( Fig 
CO postconditioning differentially regulates MAP kinase activation
Since the MAP kinase pathways play an important role in apoptosis and survival signaling, we next analyzed the effect of CO postconditioning on MAPK activation. While no CO-mediated effect on JNK phosphorylation was detectable during the experiments (data not shown), CO postconditioning after I/R suppressed I/R-induced p38 MAP kinase phosphorylation at 24 and 48 h after I/R ( Dual immunohistochemical staining against Thy-1 (which is exclusively expressed on the surface of RGC) and p-ERK-1/2 demonstrated that ERK-1/2 phosphorylation is detectable in the ganglion cell layer (GCL) after I/R, however, not in RGC (RGC are marked with white arrows in Figure 4 , 3 rd row, 4 th column, p-ERK-1/2-positive cells are marked with *). Inhalation of CO further increased p-ERK-1/2 staining in the GCL, but ERK-1/2 seemed to be phosphorylated predominantly in the RGC itself (white arrows in Fig. 4, 4 th row, 4 th column). To assess the role of HO-1, which is strongly induced during I/ R due to inflammatory oxidative cellular stress, we analyzed retinal HO-1 expression after I/R and CO inhalation. Retinal HO-1 mRNA expression (Fig. 5A, I /R 1586107 vs. I/R+CO 52646 fold induction at 12 h) and HO-1 protein expression (Fig. 5B, I 
CO attenuates glial cell activation in the retina
To further confirm these possible anti-inflammatory effects of CO postconditioning, we analyzed glial cell activation in the retina as the hallmark of reactive gliosis and neuroinflammation using GFAP (Müller cells, ''macroglia'') and Iba-1 (microglia/macrophages) staining. In the control eyes of room air or CO breathing animals, some baseline GFAP-reactivity and some Iba-1 positive cells were detectable in the GCL and the retina, respectively (data not shown). Compared to control eyes, I/R led to a robust increase in GFAP reactivity indicative of glial cell activation (Fig. 7 , left column, upper image). Furthermore, only after I/R Iba-1 positive microglia were detectable throughout all layers of the retina (left column, lower image). CO inhalation after I/R suppressed reactivity for GFAP (right column, upper image) and Iba-1 (right column, lower image).
CO inhibits ischemia-induced immigration of proliferating cells into the retina
We next addressed the question whether I/R and CO influence the proliferation of retinal cells. For this purpose we performed immunhistochemical staining against Ki-67, a marker for proliferating cells. Control eyes showed some weak Ki-67 reactivity only in endothelial cells (data not shown). However, after I/R injury positive signals for Ki-67 were evident throughout the whole retina, but predominantly in the inner retinal layers (Fig. 8, left  column, 1 st row). This was likely due to immigration of proliferating, Iba-1/Ki-67 positive microglial cells (left column, 2 nd and 3 rd row; white box). In addition, round Iba-1/Ki-67 positive cells located on top of the GCL were detected (left and right column, 2 nd and 3 rd row; white arrows). Based on their morphology, these cells were thought to be blood-borne macrophages. Furthermore, cells positive for Ki-67 and negative for Iba-1 (unclassified proliferating cells) and vice versa (non-proliferating microglia/macrophages) were also detectable. CO postconditioning abolished I/R-induced Ki-67/Iba-1 reactivity almost completely (right column, 1 st to 3 rd row) with nearly no Ki-67 positive microglia and only few macrophages (right column, 1 st to 3 rd row, white arrow) visible. In dual GFAP/Ki-67 staining, weak colocalization was detectable (white *, left column, 4 th row,), indicating only little proliferation of Müller cells. However, the inhibitory effect of CO postconditioning on I/R-induced Müller cell activation was confirmed (right column, 4 th row). To also investigate a possible link between ERK-1/2 phosphorylation and proliferating cells in the retina, we performed further immunohistochemical studies for p-ERK-1/2 and Ki-67. Ki-67 positive glial cells were not positive for p-ERK-1/2 (left column, 5 th row), which was exclusively phosphorylated in the GCL after I/R (left column, 5 th row) and further upregulated after I/R +CO (right column, 5 th row).
CO postconditioning reduces I/R-induced death of RGC
To answer the question whether these anti-inflammatory and anti-apoptotic effects of CO postconditioning may result in an increase in RGC survival after I/R-injury, we quantified the density of fluorogold-labeled RGC. RGC-densities in the retinas from corresponding control animals did not differ between the different groups ( ). When CO application was delayed for 1.5 and 3 h after initiation of reperfusion, protection was still detectable, yet to a lesser degree, which was significant at 3 h but not at 1.5 h ( 
Discussion
Treatment of cerebral injury remains difficult. The development of neuroprotective strategies in clinical situations like ischemic or hemorrhagic stroke is under continuous research. Clinical trials failed to provide an improvement of patient outcome. Nevertheless, various experimental data provide evidence that pharmacological and anesthetic agents exhibit neuroprotective properties in vitro and in vivo.
The main findings of this in vivo study in an experimental model of I/R injury can be summarized as follows: (1 reduces inflammatory oxidative cellular stress. (3) CO postconditioning exerts a significant protective effect on RGC after I/R injury with a ''therapeutic window'' of at least 3 h for the initiation of CO application after reperfusion. (5) Inhaled CO does not solely act via the ERK-1/2 pathway, since inhibition with a specific inhibitor does not counteract the CO-mediated protective effects. The findings support our hypothesis that CO postconditioning protects neuronal cells in vivo via an interdependent network of pathways. A potential interaction of the analyzed pathways is proposed in Figure 10 : CO postconditioning after retinal I/R strongly inhibits the inflammatory response and reduces RGC apoptosis, leading to higher RGC survival. However, cause and effect relationships between inflammation and apoptosis have to be investigated in the future.
Previous in vitro and in vivo studies have demonstrated that CO preconditioning exerts neuroprotective effects [7, 8] . However, the concept of preconditioning must be questioned with regard to its feasibility and transferability into clinical settings, since patients usually receive medical treatment after neuronal ischemic injury [21, 22] . In order to demonstrate CO-mediated organ protection after an injurious event, previous studies demonstrated, that CO postconditioning protect the lungs after I/R injury by inhibiting the inflammatory and apoptotic response [23] . However, the effects and the mechanisms of CO postconditioning on neuronal cells in vivo, have not been investigated.
In most cases of acute injury deposition of tissue debris is observed due to cell death. In our study, caspase-3 mRNA expression as well as caspase-3 degradation was reduced after CO postconditioning after I/R injury, revealing the anti-apoptotic effects of inhaled CO. In accordance with previous findings, CO postconditioning induced Bcl-2 and suppressed Bax gene expression after I/R injury, demonstrating CO-mediated stabilization of the mitochondrial membrane to prevent cytochrome c release and initiation of apoptosis [24] .
The three main members of the MAPK family (p38, ERK-1/2, and JNK) exert different cellular functions depending on the stimulus and timing of activation. Several experimental studies have demonstrated a differential effect of CO on MAPK activation [4, [25] [26] [27] , which in turn resulted in CO-mediated protective effects. Our data also demonstrate a differential effect of CO postconditioning on MAPK activation after I/R injury in retinal cells. Phosphorylation of p38 was suppressed by CO inhalation up to 48 h after I/R injury. Depending on which p38 kinase isoform is predominantly involved, either promotion or inhibition of apoptosis may be fostered [25, 28, 29] . Postconditioning with inhaled CO in our model of I/R seemed to suppress p38 signaling, whereas ERK-1/2 activation was increased in COtreated animals. Various in vitro and in vivo studies of retinal I/R injury suggested that activation of the ERK-1/2 pathway mediates protective effects on retinal ganglion cells [8, 30, 31] . However, our data showed that inhibition of ERK-1/2 phosphorylation with the highly selective MEK-1 inhibitor PD98059 did not attenuate the CO-mediated protective effects. This might be due to the fact that various cellular targets are influenced by CO (Fig. 10) and ERK-1/2 is not solely responsible for the observed protective effects. Further experimental in vivo studies will be necessary to further elucidate the role of ERK-1/2 in CO-mediated protection of retinal ganglion cells subjected to I/R injury.
Oxidative stress as it occurs during an inflammatory response induces the expression of HO-1 [32] . In our model, I/R injury induced HO-1 expression, whereas CO postconditioning inhibited HO-1 expression at 12 and 48 h after I/R injury. This indicates that CO postconditioning reduces oxidative stress during the inflammatory response following retinal I/R injury.
Inhibition of NF-kB activation represents a molecular mechanism of CO-mediated protection after retinal I/R injury, since activation of NF-kB contributes to neuronal cell death after ischemia, whereas inhibition of NF-kB attenuates retinal ganglion cell death [33] . I/R-induced activation of NF-kB, a central regulator of inflammatory response, was reduced by postconditioning with inhaled CO. In our work, the phosphorylation of p65/p50 heterodimer of NF-kB and the subsequent DNA binding activity was attenuated in animals receiving CO postconditioning 24 and 48 h after I/R injury respectively. These findings are indicative of the anti-inflammatory effects of CO postconditioning.
I/R injury activates glial cells and their reactivity, demonstrated by GFAP staining as an accepted marker of reactive gliosis and neuroinflammation 6 to 72 h after neuronal injury [34] . In addition, GFAP serves as a marker for the activation of retinal Müller cells (''macroglia'') [35] , which in turn promote apoptosis in RGC after I/R injury. Inhibition of glial cell activation leads to protection in models of I/R injury in the retina [36] . Our data demonstrate that Müller cell activation and reactive gliosis were inhibited by CO postconditioning, further underlining the COmediated anti-inflammatory properties in retinal I/R injury.
Microglial cells are the main effectors of the immune response following CNS injuries, including ischemia. Recent evidence suggests that the activation and immigration of microglial cells may be associated with detrimental and/or beneficial effects on adjacent neurons [37] . In acute injury, microglia has been shown to react within a few hours with a migratory response towards the lesion. Ki-67 antigen is a well-established marker for proliferating cells in the retina [38] . It is a suitable marker for the activation and proliferation of retinal glial cells (Müller cells, microglia) -the hallmarks of reactive gliosis and neuroinflammation -following retinal detachment [39] , degenerative disorders [40] , laser injury [41] or optic nerve lesion [42] . Ki-67 antigen has also been used as a marker for adult neurogenesis [43] in the brain. By dual staining with Iba-1 we were able to characterize the proliferating cells after I/R as predominantly microglia cells and fewer infiltrating macrophages, since Iba-1 is an established marker for these cells in the retina [44, 45] . The strong increase in Ki-67 and Iba-1 reactivity after I/R is most likely due to immigration of proliferating, non-residential microglia and macrophages. This is probable, since almost no Ki-67 and Iba-1 reactivity was detectable in control eyes and also blood-borne macrophages were visible, indicative of I/R-induced disturbance of the bloodbrain barrier with subsequent cellular infiltration. However, further studies will have to address the question whether increases in Ki-67-and Iba-1-reactivity are due to microglia infiltration into the retina or because of activation of residential microglial cells.
Our data demonstrate that CO postconditioning can almost completely abolish the infiltration of proliferating microglia and macrophages, adding strong evidence for the anti-inflammatory effect of CO in retinal I/R injury. Nevertheless, it remains to be investigated in the future, whether activated microglia cells in the retina induce RGC death after I/R themselves or whether these cells are merely attracted to the site of cell death and phagocytosis after the injury. Therefore, it also remains to be investigated whether CO directly inhibits activation of microglia cells or whether this ''inhibitory'' effect is rather in indicator of COmediated neuroprotection via different pathways and less RGC death. Glial proliferation was not dependent on ERK-1/2 activation, since Ki-67 positive glial cells were p-ERK-1/2 negative. p-ERK-1/2 was predominantly evident in the GCL and the RGC.
The findings of this study are in accordance with our previous ones in the same experimental model of retinal injury, where administration of the same low concentration of inhaled CO before ischemia (i.e., CO preconditioning) was associated with anti-inflammatory, anti-apoptotic and cytoprotective effects [8] . Overall, the degree of cytoprotective response was comparable between preconditioning and postconditioning, with postconditioning representing a realistic treatment option as opposed to preconditioning. Protective effects were detectable up to 7 days after I/R injury. However, no conclusions about the long-term effects on retinal ganglion cells can be drawn from this study.
Delayed onset of CO application 1.5 and 3 hours after I/R injury still exerted protective effects, extending the therapeutic window for CO application into a clinical relevant time period. Attenuation of protection at 3 h is in accordance with previous studies on CO application following neuronal injury [13] , indicating that the therapeutic window might end at this time point. However, in another study with the carbon monoxide releasing molecule CORM-3, treatment was only effective either before or 3 days after hemorrhagic neuronal injury [46] . Treatment 3 hours after injury resulted in aggravation of neuronal damage. These differences might be due to different kinetics and in vivo distribution of CO gas vs. CORM-3 and due to different models of neuronal injury (I/R vs. hemorrhagic). However, it also demonstrates that in neuronal injury timing of CO treatment is crucial.
The use of a potentially toxic gas must be carefully weighed. In this study, we used lower concentrations compared to human studies, which examined the effects of continuous carbon monoxide inhalation on carboxyhemoglobin levels. For example, volunteers breathed CO concentrations of up to 1000 ppm until their carboxyhemoglobin levels reached 10 to 12% and were then assigned to hyperbaric oxygen therapy [47] . A clinical study by Mayr et al. showed no clinical signs of CO toxicity after exposure of 250 and 500 ppm [48] . Modest increases in carboxyhemoglobin levels equivalent to that resulting from cigarette smoking do not have any appreciable acute sympathetic and hemodynamic effects in healthy humans. Furthermore, the concentrations used here are comparable to the levels used in humans (0.03%) during measurement of DLCO (lung diffusion capacity for carbon monoxide), a standard pulmonary function test [49] .
In conclusion, the present study in a model of neuronal injury demonstrates that postconditioning with inhaled CO protects retinal ganglion cells against I/R injury and cellular destruction. Possible mechanisms for these neuroprotective properties are the inhibition of microglia and macrophage infiltration leading to reduced neuroinflammation or the direct inhibition of RGC apoptosis. Future pharmacological or genetic interventions are necessary to further elucidate the distinct role of these pathways in terms of their relevance and interdependence in CO-mediated protective effects. In the future, CO might be a treatment option for acute ischemic injury to the retina and the brain. 
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